Jackson, M.D. v. NuVasive, Inc.

District Court, D. Delaware·Decided September 29, 2023·No. 1:21-cv-00053·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

ROGER P. JACKSON, M.D., Plaintiff, Vv. Civil Action No. 21-53-RGA NUVASIVE, INC., Defendant.

MEMORANDUM Before me is the Report & Recommendation of a United States Magistrate Judge. (D.1. 136). The Report addresses Plaintiff's motion to dismiss Defendant’s inequitable conduct counterclaim for failure to state a claim under Federal Rule of Civil Procedure 12(b)(6) and to strike Defendant’s equitable affirmative defenses under Federal Rule of Civil Procedure 12(f). (D.I. 96). The Report recommends that I grant the motion to dismiss without prejudice and the motion to strike. (D.I. 136 at 1). Defendant filed objections to the Report. (D.I. 139). Plaintiff responded to Defendant’s objections. (D.I. 143). I will adopt the factual findings and legal conclusions in the Report. I do not separately recite any of the facts except as I see necessary to explain my decision. I LEGAL STANDARDS Magistrate Judges have the authority to make recommendations as to the appropriate resolution of a motion to dismiss pursuant to 28 U.S.C. § 636(b)(1)(B). The Court conducts a de

novo review when determining whether to adopt a Magistrate Judge’s report and recommendation on a dispositive motion. FED. R. Civ. P. 72(b)(3). When reviewing a motion to dismiss pursuant to Rule 12(b)(6), the Court must accept the complaint’s factual allegations as true. See Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555-56 (2007). Rule 8(a) requires “a short and plain statement of the claim showing that the pleader is entitled to relief.” Jd. at 555. The factual allegations do not have to be detailed, but they must provide more than labels, conclusions, or a “formulaic recitation” of the claim elements. Jd. (“Factual allegations must be enough to raise a right to relief above the speculative level ... on the assumption that all the allegations in the complaint are true (even if doubtful in fact).”). Moreover, there must be sufficient factual matter to state a facially plausible claim to relief. Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). The facial plausibility standard is satisfied when the complaint’s factual content “allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Jd. (“Where a complaint pleads facts that are merely consistent with a defendant’s liability, it stops short of the line between possibility and plausibility of entitlement to relief.” (cleaned up)). Federal Rule of Civil Procedure 12(f) provides that a court “may strike from a pleading any insufficient defense or any redundant, immaterial, impertinent, or scandalous matter.” “A court is not required to accept affirmative defenses that are mere ‘bare bones conclusory allegations,’ and may strike such inadequately pleaded defenses.” Sun Microsystems, Inc. v. Versata Enters., Inc., 630 F. Supp. 2d 395, 408 (D. Del. 2009). “A motion to strike will not be granted where the sufficiency of the defense depends on disputed issues of facts or where it is used to determine disputed and substantial questions of law.” Cadence Pharm., Inc. v. Paddock Labs., Inc., 2012 WL 4565013, at *1 (D. Del. Oct. 1, 2012). Affirmative defenses are subject to the general pleading

requirements of Federal Rule of Civil Procedure 8. Rule 8(c)(1) requires that a party “affirmatively state any avoidance or affirmative defense.” FED. R. Civ. P. 8(c)(1). In general, the Twombly/Igbal standard under Rule 8(a) does not apply to affirmative defenses, “which need not be plausible to survive” so long as they “provide fair notice of the issue involved.” Senju Pharm. Co. v. Apotex, Inc., 921 F. Supp. 2d 297, 303 (D. Del. 2013) (internal citations and quotation marks omitted). In contrast, the equitable affirmative defenses of estoppel and unclean hands must be pled with particularity under Rule 9(b). See Sonos, Inc. v. D&M Holdings Inc., 2016 WL 4249493, at *4-5 (D. Del. Aug. 10, 2016) (finding that because fraud or misrepresentation is an element of estoppel and an element in unclean hands is based in fraud, the defenses must be pled with particularity under Rule 9(b)). IL. DISCUSSION A. Plaintiff’s Motion to Strike Plaintiff brought this lawsuit on January 19, 2021. (D.I. 1). On October 21, 2022, Plaintiff filed a second amended complaint (SAC), alleging that several of Defendant’s products infringe U.S. Patent Nos. 8,353,932 (the “’932 patent”); 8,696,711 (the “’711 patent’); 9,788,866 (the patent”); 10,335,200 (the “’200 patent”); 10,561,444 (the “’444 patent”); 10,722,273 (the patent”); 9,808,292 (the “’292 patent”); and 11,051,856 (the “’856 patent”) (the “Asserted Patents”). (D.I. 77). The Asserted Patents generally relate to spinal implant systems involving separate components used to align a patient’s vertebrae. (/d. at § 8). Defendant filed a motion to dismiss the complaint under Rule 12(b)(1) for lack of standing based on a 2014 agreement that Defendant alleged had assigned all substantial right to the Asserted Patents to it and that Plaintiff had granted Defendant a covenant not to sue. (D.I. 8). On February 11, 2022, I denied Defendant’s motion, finding that on the record available at the time, Plaintiff had standing to bring the lawsuit.

(D.I. 36). Defendant filed its answer and counterclaims to the SAC on December 5, 2022. (D.I. 89). Its fourth, fifth, and sixth affirmative defenses are waiver, equitable estoppel, and unclean hands, respectively. (Id. at {J 201-203). Defendant alleges in its counterclaims that under the 2014 agreement, Plaintiff gave Defendant intellectual property rights, freedom to operate, and a covenant not to sue for $30 million. (D.I. 89, Counterclaims at {J 92-97, 103). Plaintiff moves to strike Defendant’s fourth, fifth, and sixth affirmative defenses, arguing that Defendant has not pled sufficient facts under Rule 9(b). (D.I. 97 at 19). Plaintiff also argues that because I have already rejected the theories underlying these defenses related to the 2014 Agreement, striking the defenses is appropriate to streamline the case. (/d. at 20). The Report recommends that I grant Plaintiff's motion to strike the affirmative defenses. (D.I. 136 at 16). Defendant objects to the Magistrate Judge’s conclusion that my ruling on its motion to dismiss constitutes the “law of the case” that the 2014 agreement did not give Defendant rights to the Asserted Patents, freedom to operate, or a covenant not to sue. (D.I. 139 at 4).! Defendant argues that the Report incorrectly assumes that the basis for its affirmative defenses are “co- extensive” with the arguments it made in its motion to dismiss, and that the Magistrate Judge erred in not considering the substantive elements of waiver, estoppel, and unclean hands. (/d. at 2-3). Plaintiff notes that while it argued in its opening brief that I had already rejected the contention that Plaintiff had sold or assigned any of the Asserted Patents in my ruling on Defendant’s motion

Free access — add to your briefcase to read the full text and ask questions with AI

Jackson, M.D. v. NuVasive, Inc., (D. Del. 2023).

Jackson, M.D. v. NuVasive, Inc. (Jackson, M.D. v. NuVasive, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Exergen Corp. v. Wal-Mart Stores, Inc.
575 F.3d 1312 (Federal Circuit, 2009)
Therasense, Inc. v. Becton, Dickinson and Co.
649 F.3d 1276 (Federal Circuit, 2011)
Delano Farms Co. v. California Table Grape Commission
655 F.3d 1337 (Federal Circuit, 2011)
Symbol Technologies, Inc. v. Aruba Networks, Inc.
609 F. Supp. 2d 353 (D. Delaware, 2009)
Sun Microsystems, Inc. v. Versata Enterprises, Inc.
630 F. Supp. 2d 395 (D. Delaware, 2009)
Jimenez v. Comm Social Security
46 F. App'x 684 (Third Circuit, 2002)
Senju Pharmaceutical Co. v. Apotex, Inc.
921 F. Supp. 2d 297 (D. Delaware, 2013)
Stephanie Higgins v. Bayada Home Health Care Inc
62 F.4th 755 (Third Circuit, 2023)